Snowden Capital Advisors LLC Dexcom Inc Transaction History

Snowden Capital Advisors LLC

$3.29 Billion
Q3 2024

A detailed history of Snowden Capital Advisors LLC transactions in Dexcom Inc stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 6,622 shares of DXCM stock, worth $502,477. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,622

Previous 7,837 15.5%

Holding current value

$502,477

Previous $888,000 50.11%

% of portfolio

0.01%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $77,760 - $141,012	-1,215 Reduced 15.5%	6,622 $443,000
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $51,404 - $65,449	466 Added 6.32%	7,837 $888,000
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $205,938 - $252,600	1,803 Added 32.38%	7,371 $1.02 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $35,555 - $58,479	471 Added 9.24%	5,568 $690,000
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $170,226 - $272,825	-1,978 Reduced 27.96%	5,097 $475,000
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $46,450 - $54,094	-413 Reduced 5.52%	7,075 $909,000
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $130,728 - $154,510	-1,257 Reduced 14.37%	7,488 $869,000
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $152,624 - $220,315	1,796 Added 25.85%	8,745 $990,000
Q3 2022 Nov 09, 2022	BUY	$76.35 - $94.18 $4,810 - $5,933	63 Added 0.91%	6,949 $559,000
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $407,600 - $796,675	5,995 Added 672.84%	6,886 $513,000
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $78,839 - $109,107	838 Added 1581.13%	891 $455,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $6,883 - $8,629	53 New	53 $28,000
Q3 2021 Feb 05, 2024	SELL	$106.71 - $143.18 $481,262 - $645,741	-4,510 Reduced 88.48%	587 $321 Million
Q2 2021 Jan 08, 2024	BUY	$80.99 - $107.93 $47,379 - $63,139	585 New	585 $250 Million
Q1 2020 Jan 08, 2024	SELL	$47.79 - $75.63 $645,165 - $1.02 Million	-13,500 Closed	0 $0
Q4 2019 Jan 08, 2024	SELL	$36.62 - $57.29 $18,310 - $28,645	-500 Reduced 3.57%	13,500 $29.5 Million
Q3 2019 Jan 08, 2024	SELL	$35.53 - $43.8 $213,180 - $262,800	-6,000 Reduced 30.0%	14,000 $20.9 Million
Q2 2019 Jan 08, 2024	BUY	$27.84 - $38.92 $414,899 - $580,024	14,903 Added 292.39%	20,000 $20.8 Million

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Account

Snowden Capital Advisors LLC Dexcom Inc Transaction History